2025 Nobel Prize in Physiology or Medicine Honors Discoveries of Regulatory T Cells and the Foxp3 Gene

The 2025 Nobel Prize in Physiology or Medicine has been awarded jointly to Mary E. Brunkow, Fred Ramsdell, and Shimon Sakaguchi for their groundbreaking discoveries that transformed modern immunology. Their pioneering research on regulatory T cells (Tregs) and the Foxp3 gene revealed how the body’s immune system maintains balance — a discovery that revolutionized our understanding of autoimmune diseases and immune tolerance.

A Turning Point in 1995: Sakaguchi’s Groundbreaking Discovery

In 1995, Dr. Shimon Sakaguchi from Osaka University challenged the leading theory of immune self-tolerance. Most scientists believed tolerance developed only in the thymus through central tolerance. Sakaguchi thought the immune system had more complex regulatory layers.

His research identified a special group of immune cells that suppressed unwanted immune attacks. These cells became known as regulatory T cells (Tregs). Tregs prevent the immune system from damaging the body’s own tissues. This discovery changed how scientists understood autoimmune diseases and immune regulation. It also launched the modern study of peripheral immune tolerance, a key field in immunology today.

Foxp3: The Gene That Keeps the Immune System in Check

In 2001, Mary E. Brunkow and Fred Ramsdell discovered the missing genetic link in immune tolerance. They studied mice that developed multiple autoimmune disorders. Their question was simple: Why does their immune system lose control? They found the answer in a gene called Foxp3.

Mutations in Foxp3 caused immune system breakdown and severe inflammation. The same mutation in humans leads to IPEX syndrome, a rare genetic autoimmune disease. This was the first time scientists connected one gene directly to immune regulation. Their work built the foundation for understanding autoimmune disorders at the genetic level.

2003: When Discoveries Converged

Just two years later, Dr. Sakaguchi demonstrated that forcing normal T cells to express Foxp3 could transform them into functional Tregs.

This breakthrough proved that Foxp3 was not merely a marker, but a main regulator controlling the development and suppressive functions of regulatory T cells. Tregs, guided by Foxp3, act like the immune system’s internal peacekeepers — ensuring stability, preventing self-destruction, and maintaining the delicate balance between defense and tolerance.

A New Era for Autoimmune and Cancer Therapies

“Nobody imagined that self-tolerance depended on one small set of T cells,” said Olle Kämpe, Chair of the Nobel Committee. “Their discoveries are essential for understanding why most people do not develop autoimmune diseases.”

The trio’s findings opened a new era in immune tolerance research. Their discoveries guide modern therapies for autoimmune disease, cancer immunotherapy, and organ transplantation. Today, several Treg-based therapies are being tested in global clinical trials. These studies aim to restore immune balance and improve patient outcomes.

The 2025 Nobel Prize recognizes research that continues to shape medicine today. As many experts note, the age of immune regulation and targeted immunotherapy has begun.

Author

Steven Chung

紅杏枝頭春意鬧固然是眾人所追求的風景，但我願意說，青蘿拂行衣更能湧生感嘆。 願在海量晦澀的生醫資訊中，為您點亮一座心燈塔。鐘煌翔